New Insights for Huntington's Disease Treatment

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cells of the Nervous System".

Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 295

Special Issue Editors


E-Mail Website
Guest Editor
Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul 02792, Korea
Interests: Huntington’s disease; epigenetics; neurodegeneration; non-cell autonomous pathway
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Neurology, Boston University School of Medicine, Boston, MA 02130, USA
Interests: Huntington’s disease; neuropathology; gliogenesis; neuroinflammation; oxidative stress

Special Issue Information

Dear Colleagues,

Huntington’s disease (HD) is a progressive neurodegenerative disorder with symptoms such as uncoordinated motor movement, emotional disturbance, and cognitive abnormality. The initial manifestation of HD occurs in midlife, and progressive decline after onset leads to inevitable fatality. More than 150 years after its initial clinical description by George Huntington, we know that HD is associated with numerous neuropathological changes. These changes include significant neuronal loss, astrogliosis, and gross degeneration of the caudate nucleus and the putamen. Moreover, the initial phase of HD has a greatest influence on medium spiny neurons (MSNs). This indicates a particular neuronal vulnerability and topographic susceptibility that is selectively patterned. Since the Huntington’s Disease Collaborative Research Group’s genetic investigation identified the HTT (huntingtin) gene (known as interesting transcript 15 on the chromosome 4) in 1993, many studies have determined the pathologic mechanisms of HTT in MSNs. However, a direct mechanism to explain the pathway from genetic mutation to neuronal atrophy has not yet been fully understood. Today, a growing body of evidence points toward epigenetic modification as being part of a fundamental molecular mechanism involved in HD pathogenesis. Even though HD is highly investigated, there is currently no applicable clinical treatment that can delay the onset or slow the disease progression of HD. Together, the key to discovering biological markers and therapeutics for the treatment of HD may potentially be possible through breakthrough research. In this context, this Special Issue of Cells invites research or review manuscripts on new insights for HD treatment and advanced neuropathological mechanisms of HD. The issue also invites manuscripts on AI platform-based therapeutic approaches in HD.

Prof. Dr. Hoon Ryu
Dr. Junghee Lee
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Huntington’s disease
  • medium spiny neurons
  • therapeutics
  • neuropathology
  • epigenetics
  • non-cell autonomous pathway
  • GABA
  • dopamine
  • chorea

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop